Andrew Brackin, Partner at Gradient Ventures, on AI Startups & HealthTech - podcast episode cover

Andrew Brackin, Partner at Gradient Ventures, on AI Startups & HealthTech

Jul 12, 202559 min
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

Andrew Brackin is a Partner at Gradient Ventures. ~~~~~This episode is brought to you by Verivend. If you’re a GP or LP looking to simplify the capital raising and deployment process, Verivend is here to help. Trusted by over 800 funds and managing more than $2 billion in transactions, Verivend offers a secure, streamlined payments platform designed specifically for private capital markets. Say goodbye to manual reconciliation and repeated follow-ups - raise and deploy capital faster and with greater transparency. Ready to make your fund operations smoother? Visit https://bit.ly/3GrB4Qj and see how easy it can be.~~~~~Prior to Gradient, Andrew co-founded Vial, a tech-enabled clinical trial platform that raised over $100M in venture capital from top-tier firms. Prior to Vial, he was part of the founding team and the Head of Growth at Newfront (YC W18), an AI-powered commercial insurance brokerage valued at $2.2BN, insuring numerous Fortune 500 companies. His career began at Jobr, a mobile job search business that Monster.com acquired in 2016. Andrew was a 2013 recipient of the Thiel Fellowship. Outside of work, he loves reading about global affairs, working out at Barry’s Bootcamp, and enjoying live music.Topics:

  • Lessons from raising $100M+ and building in a complex, regulated industry
  • Sectors that are overhyped vs. undervalued in today's market
  • Predictions for the next wave of healthcare innovation

#StartupLeadership #HealthTech #VentureCapital #ThielFellowship #AIinInsurance

For the best experience, listen in Metacast app for iOS or Android